|  | LPFS (months) | ||
---|---|---|---|---|
Variables | Case | Mean | Median | P-value |
Total | Â | Â | Â | 0.010 |
   Low expression | 53 | 33.5 | 20.6 |  |
   High expression | 45 | 19.4 | 10.4 |  |
T status | Â | Â | Â | Â |
   T2-3 |  |  |  | 0.048 |
Low expression | 31 | 39.4 | 33.1 | Â |
High expression | 16 | 25.9 | 20.0 | Â |
   T4 |  |  |  | 0.224 |
Low expression | 22 | 23.6 | 9.7 | Â |
High expression | 29 | 12.9 | 8.6 | Â |
N status | Â | Â | Â | Â |
   N0 |  |  |  | 0.005 |
Low expression | 8 | 62.5 | NRa | Â |
High expression | 8 | 11.9 | 7.4 | Â |
   N1 |  |  |  | 0.230 |
Low expression | 40 | 26.2 | 13.6 | Â |
High expression | 42 | 20.5 | 12.7 | Â |
M status | Â | Â | Â | Â |
   M0 |  |  |  | 0.018 |
Low expression | 33 | 40.8 | 29.5 | Â |
High expression | 26 | 22.6 | 10.4 | Â |
   M1-lym |  |  |  | 0.117 |
Low expression | 20 | 20.5 | 14.7 | Â |
High expression | 19 | 13.4 | 9.9 | Â |
CRT response | Â | Â | Â | Â |
   Effective |  |  |  | 0.022 |
Low expression | 37 | 40.2 | 29.6 | Â |
High expression | 24 | 24.0 | 14.1 | Â |
   Resistant |  |  |  | 0.715 |
Low expression | 16 | 14.9 | 8.6 | Â |
   High expression | 21 | 12.6 | 8.5 |  |